Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) and Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations. Profitability This table compares Neurocrine Biosciences and Jasper […]
Voyager Therapeutics (NASDAQ:VYGR – Free Report) had its target price reduced by Wedbush from $10.00 to $8.00 in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. Wedbush also issued estimates for Voyager Therapeutics’ Q2 2024 earnings at ($0.46) EPS, Q3 2024 earnings at […]
NO-BOundaries Voyager 1 E-Bike Launched on Indiegogo openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Oppenheimer reissued their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Oppenheimer currently has a $18.00 price objective on the stock. Several other analysts also recently commented on the stock. StockNews.com downgraded shares of Voyager Therapeutics from a buy rating to […]
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Monday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.
ZIVO Bioscience (NASDAQ:ZIVO) and Neurocrine Biosciences (NASDAQ:NBIX) Head to Head Comparison themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
SummerHaven Investment Management LLC increased its stake in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,146 shares of the company’s stock after purchasing an additional 1,367 shares […]